EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies Post author:Sam Post published:April 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Acucela Granted New Patent Covering Method Of Use For Emixustat Hydrochloride September 10, 2017 Exec Reveals Sanofi is Hunting for M&As to Boost Diabetes Biz April 19, 2017 4 Top-Performing S&P 500 Biotech Stocks of 2017 December 27, 2017